M. Morille, C. Passirani, A. Vonarbourg, A. Clavreul, and J. Benoit, Progress in developing cationic vectors for non-viral systemic gene therapy against cancer, Biomaterials, vol.29, issue.24-25, pp.24-253477, 2008.
DOI : 10.1016/j.biomaterials.2008.04.036

URL : https://hal.archives-ouvertes.fr/inserm-00353462

M. Kazatchkine and M. Carreno, Activation of the complement system at the interface between blood and artificial surfaces, Biomaterials, vol.9, issue.1, pp.30-35, 1988.
DOI : 10.1016/0142-9612(88)90066-X

A. Vonarbourg, C. Passirani, P. Saulnier, and J. Benoit, Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, issue.24, pp.4356-4373, 2006.
DOI : 10.1016/j.biomaterials.2006.03.039

B. Heurtault, P. Saulnier, B. Pech, J. Proust, and J. Benoit, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharmaceutical Research, vol.19, issue.6, pp.875-880, 2002.
DOI : 10.1023/A:1016121319668

A. Vonarbourg, C. Passirani, P. Saulnier, P. Simard, J. Leroux et al., Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, vol.21, issue.3, pp.620-628, 2006.
DOI : 10.1002/jbm.a.30711

O. Zelphati, L. Uyechi, L. Barron, F. Szoka, and J. , Effect of serum components on the physicochemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cells

V. Mosqueira, P. Legrand, A. Gulik, O. Bourdon, R. Gref et al., Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules, Biomaterials, vol.22, issue.22, pp.2967-2979, 2001.
DOI : 10.1016/S0142-9612(01)00043-6

Z. Cui and R. Mumper, Plasmid DNA-Entrapped Nanoparticles Engineered from Microemulsion Precursors:?? In Vitro and in Vivo Evaluation, Bioconjugate Chemistry, vol.13, issue.6, pp.1319-1327, 2002.
DOI : 10.1021/bc0255586

T. Zimmermann, A. Lee, A. Akinc, B. Bramlage, D. Bumcrot et al., RNAi-mediated gene silencing in non-human primates, Nature, vol.23, issue.7089, pp.111-114, 2006.
DOI : 10.1038/nature04688

Y. Zhang, L. Sekirov, E. Saravolac, J. Wheeler, P. Tardi et al., Stabilized plasmid-lipid particles for regional gene therapy: formulation and transfection properties, Gene Therapy, vol.6, issue.8, pp.1438-1447, 1999.
DOI : 10.1038/sj.gt.3300965

J. Wheeler, L. Palmer, M. Ossanlou, I. Maclachlan, R. Graham et al., Stabilized plasmid-lipid particles: construction and characterization, Gene Therapy, vol.6, issue.2, pp.271-281, 1999.
DOI : 10.1038/sj.gt.3300821

K. Mok, A. Lam, and P. Cullis, Stabilized plasmid-lipid particles: factors influencing plasmid entrapment and transfection properties, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1419, issue.2, pp.137-150, 1999.
DOI : 10.1016/S0005-2736(99)00059-0

URL : http://doi.org/10.1016/s0005-2736(99)00059-0